Google is testing standard text and Shopping ads for certain pharmaceutical products, including prescription drugs, inside AI Mode and AI Overviews in the United States, giving drug advertisers a new way to reach people asking health questions in Google’s AI-powered search surfaces.
What is changing in AI Mode and AI Overviews
Google confirmed it has “recently expanded to include certain pharmaceutical products” within ads on these AI surfaces. The expansion covers standard text ads and Shopping ads. The placements appear in sections labeled “Sponsored,” separating paid results from the AI-generated answers around them.
The testing began this month and is limited to the U.S., according to the company. Ads are delivered through Google’s existing pharmaceutical advertising channel, which is governed by separate certification and policy rules from general search ads.
How the ads appear to users
Anyone searching a health-related question and receiving an AI Overview or switching into AI Mode may now see drugmaker and pharmacy ads in the same flow. The Sponsored label keeps the placement identifiable as paid, sitting inside or alongside the AI-generated response.
Early-stage testing means the format is not fully rolled out. Ads may appear inconsistently across queries, regions within the U.S., and device types while Google measures performance and policy compliance.
What is not changing
Google has not announced new pharmaceutical advertising policies alongside this expansion. The last documented updates to those policies were in March 2026 and October 2025, with additional regional changes in specific countries over the past year.
Pharmaceutical advertisers continue to operate under Google’s existing certification requirements, which gate which companies and products can run drug-related ads at all. The AI Mode and AI Overviews expansion inherits those requirements rather than relaxing them.
Why this matters for advertisers and searchers
AI Overviews and AI Mode are eating into the top of the search results page, pushing traditional text ads and organic links further down. Adding pharmaceutical ads to these surfaces gives drug brands a way to stay visible where health queries are increasingly being answered, but it also means searchers comparing medications, symptoms, or treatment options will see paid placements inside the AI answer itself.
For advertisers, the immediate question is whether campaigns targeting pharmaceutical keywords will now serve inside AI-generated answers, and whether bidding and quality-score mechanics change as a result. Google has not published new guidance on this point.
For users, the practical effect is straightforward: the same prescription drug ad that could appear at the top of a standard Google results page can now appear inside the AI summary on the same query, marked as Sponsored.
What to watch next
Three signals will show whether this expansion is sticking. First, how often pharmaceutical ads actually render in AI Mode and AI Overviews during the U.S. test, and whether the format spreads to other countries. Second, whether Google updates its pharmaceutical advertising policies to address AI-surface placements specifically, or treats them as covered by existing rules. Third, how competitors in health search, including AI search tools from other companies, respond if their own ad surfaces open up to drug advertisers.
FAQ
Is Google showing pharmaceutical ads in AI Mode and AI Overviews?
Google confirmed it is testing standard text and Shopping ads for certain pharmaceutical products, including prescription drugs, inside AI Mode and AI Overviews. The testing is limited to the U.S. and began this month.
Are prescription drug ads now allowed in Google AI Overviews?
Prescription drug advertisers can run standard text and Shopping ads within AI Mode and AI Overviews during the test. The ads appear in sections labeled “Sponsored” and are governed by Google’s existing pharmaceutical advertising certification requirements.
Did Google change its pharmaceutical ad policy for AI surfaces?
No new pharmaceutical advertising policy has been announced. The last documented policy updates were in March 2026 and October 2025, plus regional changes in specific countries. The AI Mode and AI Overviews expansion runs on top of the existing rules.
Try the AI visibility report
SEOScanPro runs a full technical audit of a site and shows the measured result behind every check. Open the AI visibility report.